What is the clinical evidence from this study?

Study design: Case-Control. Population: Equine hyperlipaemia (n=36). Intervention: Hyperlipaemia vs. Healthy ponies. Primary outcome: Plasma lipoprotein concentration and composition.

September 1, 1992Equine Veterinary Journal

Plasma lipids, lipoproteins and post‐heparin lipases in ponies with hyperlipaemia

View Full Paper

Ask AI

Bookmark

Key result

Equine hyperlipaemia linked to ~52-fold higher triglycerides versus healthy controls, driven by VLDL overproduction.

n=36

Authors

TWT. D. G. WatsonUniversity College of the North LBL. BurnsInstitute on Aging SLS. LoveAcademy of Nutrition and Dietetics

Discussion

Member takes

Implication

May guide equine hyperlipaemia management; leaves open whether VLDL-targeted interventions warrant trials.

Study Design

Type

Case-Control (n=36)

PICO

Population

36 ponies, comprising 18 with hyperlipaemia and 18 healthy controls, evaluated for plasma lipoprotein concentration and composition.

Exposure / Comparator

Hyperlipaemia vs Healthy ponies

Primary Outcome

Plasma lipoprotein concentration and composition

Cite This Study

Watson et al. (1992) conducted a case-control in Equine hyperlipaemia (n=36). Hyperlipaemia vs. Healthy ponies was evaluated on Plasma lipoprotein concentration and composition. Equine hyperlipaemia was associated with 4-, 52-, and 19-fold increases in cholesterol, triglyceride, and VLDL concentrations compared to healthy controls, driven by VLDL overproduction.

synapsesocial.com/papers/6aa2ec52eb5cc5d2cba591d4 https://doi.org/10.1111/j.2042-3306.1992.tb02852.x

View Full Paper

Ask AI

Bookmark

Plasma lipids, lipoproteins and post‐heparin lipases in ponies with hyperlipaemia

Discussion

Member takes

Implication

Study Design

PICO

Cite This Study

Plasma lipids, lipoproteins and post‐heparin lipases in ponies with hyperlipaemia

Discussion

Member takes

Implication

Study Design

PICO

Cite This Study

Also Consider

Also Consider